Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion type Assertion NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_head.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion description "[The results provide clinical implications that therapeutic targeting at the BRAF/MEK/MAP kinase pathway may be a good approach in restoring thyroid gene expression for effective radioiodine therapy for BRAF mutation-harboring PTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_provenance.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion evidence source_evidence_literature NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_provenance.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion SIO_000772 17317846 NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_provenance.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion wasDerivedFrom befree-20140225 NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_provenance.
- NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_assertion wasGeneratedBy ECO_0000203 NP618659.RA_7g_3j732E5uf51vnMhnQW0xweZISSJWQEijlU9vUn4130_provenance.